Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
Clinical trial NCT06522035 · TERMINATED
Trial details
- NCT number
- NCT06522035
- Sponsor
- Enlivex Therapeutics Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-10-20
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.